Treatment with IL2/vaccinia recombinant virus leads to serologic, histologic and phenotypic normalization of autoimmune MRL/lpr-lpr mice.
about
IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cellsLow-Dose IL-2 in the Treatment of Lupus.Lupus nephritis reoccurs following transplantation in the lupus prone mouse.Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.
P2860
Treatment with IL2/vaccinia recombinant virus leads to serologic, histologic and phenotypic normalization of autoimmune MRL/lpr-lpr mice.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Treatment with IL2/vaccinia re ...... f autoimmune MRL/lpr-lpr mice.
@en
Treatment with IL2/vaccinia re ...... f autoimmune MRL/lpr-lpr mice.
@nl
type
label
Treatment with IL2/vaccinia re ...... f autoimmune MRL/lpr-lpr mice.
@en
Treatment with IL2/vaccinia re ...... f autoimmune MRL/lpr-lpr mice.
@nl
prefLabel
Treatment with IL2/vaccinia re ...... f autoimmune MRL/lpr-lpr mice.
@en
Treatment with IL2/vaccinia re ...... f autoimmune MRL/lpr-lpr mice.
@nl
P2093
P2860
P1433
P1476
Treatment with IL2/vaccinia re ...... of autoimmune MRL/lpr-lpr mice
@en
P2093
Gutierrez-Ramos JC
Martinez C
P2860
P356
10.3109/08916939108997143
P577
1991-01-01T00:00:00Z